Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINE1 | P05121 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 4/20 | 0.38 |
| ▸ | PTGES | O14684 | 2/20 | 0.38 |
| ▸ | RXRA | P19793 | 1/20 | 0.38 |
| ▸ | RXRB | P28702 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | KIF11 | P52732 | 2/20 | 0.37 |
| ▸ | PGR | P06401 | 1/20 | 0.37 |
| ▸ | RORA | P35398 | 1/20 | 0.37 |
| ▸ | RORC | P51449 | 1/20 | 0.37 |
| ▸ | RORB | Q92753 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 2/20 | 0.36 |
| ▸ | TSPO | P30536 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11910782 | 0.97 | SERPINE1 (0.39) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL262622 | 0.97 | KDM4E (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL262727 | 0.97 | KDM4E (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL13761686 | 0.97 | KMT2A (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL13761645 | 0.97 | KMT2A (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL13761685 | 0.97 | KMT2A (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL13761641 | 0.97 | KMT2A (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL262397 | 0.97 | KMT2A (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL13761687 | 0.97 | KMT2A (0.42) | SERPINE1KMT2APPARGPTGESRXRA | |
| SCHEMBL13761643 | 0.97 | KMT2A (0.42) | SERPINE1KMT2APPARGPTGESRXRA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9136479-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-9136479-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2015-09-15 | — | — | US | disclosed |
| US-20150004731-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING THE ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LAB (JP) | 2015-01-01 | — | — | US | disclosed |
| US-8816098-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8816098-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using the anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2014-08-26 | — | — | US | disclosed |
| US-8530672-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-8530672-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-09-10 | — | — | US | disclosed |
| US-20120309984-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-20120309984-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-12-06 | — | — | US | disclosed |
| US-8278655-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| US-8278655-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-10-02 | — | — | US | disclosed |
| US-20120104379-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-05-03 | — | — | US | disclosed |
| US-8134147-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-8134147-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2012-03-13 | — | — | US | disclosed |
| US-20100200847-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
| US-20100200847-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-08-12 | — | — | US | disclosed |
| US-7723722-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
| US-7723722-B2 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2010-05-25 | — | — | US | disclosed |
| EP-1972619-A1 | Organic compound, anthracene derivative, and light-emitting element, light-emitting device, and electronic device using anthracene derivative | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2008-09-24 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120104379-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | CYP1A1, XPO7, AMY1A | SERPINE1 1684/4885KMT2A 3499/4885PPARG 1293/4885 |
| US-20120309984-A1 | ORGANIC COMPOUND, ANTHRACENE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING ANTHRACENE DERIVATIVE | CYP1A1, XPO7, AMY1A | SERPINE1 1684/4885KMT2A 3499/4885PPARG 1293/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.